CorMedix Inc.
CRMD
$6.10
-$0.20-3.18%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 172.43% | 1,321.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 172.43% | 1,321.18% | |||
| Cost of Revenue | 71.22% | 34.68% | |||
| Gross Profit | 178.88% | 3,534.66% | |||
| SG&A Expenses | 15.32% | -10.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.95% | -8.46% | |||
| Operating Income | 493.51% | 78.52% | |||
| Income Before Tax | 584.89% | 80.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 584.89% | 80.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 584.89% | 80.38% | |||
| EBIT | 493.51% | 78.52% | |||
| EBITDA | 507.17% | 78.92% | |||
| EPS Basic | 563.77% | 80.78% | |||
| Normalized Basic EPS | 563.73% | 80.78% | |||
| EPS Diluted | 563.77% | 80.78% | |||
| Normalized Diluted EPS | 563.73% | 80.78% | |||
| Average Basic Shares Outstanding | 4.56% | 2.09% | |||
| Average Diluted Shares Outstanding | 4.56% | 2.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
